Results 141 to 150 of about 40,253 (233)

NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial. [PDF]

open access: yesESMO Open
Macarulla T   +19 more
europepmc   +1 more source

Vascular Dysfunction in Colorectal Cancer: Scoping Review of Current Evidence for Guiding Future Research. [PDF]

open access: yesJ Gastrointest Cancer
DeJonge SR   +4 more
europepmc   +1 more source

NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial. [PDF]

open access: yesNat Commun
Gao C   +35 more
europepmc   +1 more source

Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT-An International, Randomized, Phase III, Noninferiority Trial. [PDF]

open access: yesJ Clin Oncol
Iveson T   +31 more
europepmc   +1 more source

Defining the Prognostic Significance of BRAF V600E in Early-Stage Colon Cancer: A Systematic Review and Meta-Analysis. [PDF]

open access: yesCurr Oncol
Dankner M   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy